CONMED
CNMD
239 hedge funds and large institutions have $3.12B invested in CONMED in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 94 increasing their positions, 88 reducing their positions, and 37 closing their positions.
11% more capital invested
Capital invested by funds: $2.8B → $3.12B (+$319M)
2.89% more ownership
Funds ownership: 114.51% → 117.4% (+2.9%)
7% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 88
5% less funds holding
Funds holding: 252 → 239 (-13)
17% less call options, than puts
Call options by funds: $53M | Put options by funds: $63.9M
24% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 37
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$37.6M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
+$27.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20.1M |
| 4 |
Morgan Stanley
New York
|
+$16.8M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$11.4M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$36.4M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$21.9M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
-$20.6M |
| 4 |
Goldman Sachs
New York
|
-$10.8M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$10.2M |
CNMD Hedge Fund Activity: Q4 2022 in Review
239 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2022, worth a combined $3.12B — up 11% from $2.8B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of CNMD and 28 opened new positions — a net loss of 9 holders — while 88 trimmed existing stakes and 94 added.
The largest buyer was Capital Research Global Investors, adding an estimated $37.6M. The largest seller was Invesco, cutting an estimated $36.4M.
- 239 institutional investors held CONMED (CNMD) as of Q4 2022, down from 252 in Q3 2022.
- Funds reported $3.12B of CONMED stock for Q4 2022, up 11% quarter-over-quarter.
- 28 funds opened new CONMED positions in Q4 2022 and 37 closed out, a net change of -9 holders.
- The largest CONMED buyer in Q4 2022 was Capital Research Global Investors, an estimated $37.6M added.
- The largest CONMED seller in Q4 2022 was Invesco, an estimated $36.4M sold.
Based on aggregated 13F filings for Q4 2022.